Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Donnellan joined Sarah Cannon in 2014 and serves as Director of Leukemia/Myelodysplastic Syndromes Research and an investigator of hematologic malignancies. In his role, Dr. Donnellan oversees research surrounding myeloid stem cell disorders including myelodysplastic syndrome, acute myeloid leukemia and myeloproliferative neoplasms for the Sarah Cannon program in Nashville. He received his undergraduate degree from Auburn University and his medical degree from the University of Alabama School of Medicine. He performed his internal medicine residency at the University of Alabama, Birmingham where he received the C. Glenn Cobbs Award for excellence at the Birmingham VA Medical Center and the Claude Bennett Award for outstanding performance at University Hospital. He then completed a fellowship in hematology/oncology at the University of Alabama, Birmingham with a special focus in blood and marrow transplantation. He is board certified in internal medicine, hematology and medical oncology. Additionally, he is an associate with Tennessee Oncology, PLLC.